Le manifestazioni ematologiche della sindrome da ... - Salute per tutti

114
Scripta MEDICA
Volume 7, n. 4, 2004
24. Giesepke J, Scalia-Tomba G, Hakansson C,
Karlsson A, Lidman K. Incubation time of AIDS: progression
of disease in a cohort of HIV-infected homo and
bisexual men with known dates of infection. Scand. J Infect
Dis, 1990; 22:407
25. Pileri S, Rivano MT, Raise et al. The value of lymphonode
biopsy in patients with the acquired immunodeficiency
sindrome (AIDS) and the AIDS-related complex
(ARC): a morphological and immunohistochemical study of
90 cases. Histopathol 1986; 10:1107
26. Centers for disease control. Classification system for
human T-lymphotropic virus type III/lymphadenopathyassociated
virus infections. Morbid Mortal Week Rep 1986;
35:334
27. Bottinger B, Morfeldt, Manson L, Putkonen P,
Nilsson B, Julander I, Biberfeld G. Predictive markers of
AIDS: a follow-up of lymphocyte subsets and HIV serology
in a cohort of patients with lymphadenopathy. Scand. J
Infect Dis 1989; 86:533
28. Goedert JJ, Biggar RJ, Melbye M, et al. Effect of T4
count and cofactors on the incidence of AIDS in homosexual
men infected with human immunodeficiency virus.
JAMA 1987; 257:331
29. Murray HW, Godblod JH, Jurica K, Roberts RB.
Progression to AIDS in patients with lymphoadenopathy or
AIDS-related complex reappraisal of risk and predictive
factors. Am J Med 1989; 86:533
30. Diebold J, Marche C, Audovin J, et al. Lymphnode
modification in patients with the acquired immunodeficiency
sindrome (AIDS) or with AIDS-related complex (ARC). A
histological, immunohistopathological and ultrastructural
study of 45 cases. Pathol Res Prac 1985; 180:590
31. Steis RG, Longo DL. Clinical, biologic and therapeutic
aspects of malignancies associated with the acquired immunodeficiency
syndrome. Part 1 Ann Allergy 1988; 60:310
32. Knowles DM, Chamulak GA, Subar M, et al. Lymphoid
neoplasia associated with the acquired immunodeficiency
syndrome (AIDS). The New York University
Medical Center experience with 105 patients (1981-1986).
Ann Intern Med 1988; 108:744
33. Lemp GF, Payne SF, Neal D, Temelso T, Rutherford
GW. Survival trends for patients with AIDS JAMA 1990;
263:402
34. Sakaguchi M, Sato T, Groopman JE. Human immunodeficiency
virus infection of megakaryocitic cells. Blood
1991; 77:481
35. SUN NCJ, Shapshak P, Lachant NA, et al. Bone
marrow examination in patients with AIDS and AIDSrelated
complex(ARC). Am J Clin Pathol 1989; 92:589
36. Von Laer D, Huffert FT, Fenner TE, et al. CD 34 +
hematopoietic progenitor cells are not a major reservoir of
the human immunodeficiency virus. Blood, 1990; 76:1281
37. Kaczmarski RS, Davison F, Blair E, et al. Detection
of HIV in haemopoietic progenitors. Br J Haematol 1992;
82:764
38. Louache F, Henri A, Bettaieb A, et al. Role of human
immunodeficiency virus replication in defective in vitro
growth of hematopoietic progenitors. Blood 1992; 80:2991
39. Embretson J, Zupancic M, Ribas JL, et al. Massive
covert infection of helper T lymphocytes and macrophages
by HIV during the incubation period of AIDS. Nature
1993; 362:359
40. Gendelman HE, Orenstein JM, Baca LM, et al. The
macrophage in the persistence and pathogenesis of HIV
infection. AIDS, 1989,3,475
41. Esser B, Glienke W, Von Briesen, et al. Differential
regulation of proinflammatory and hematopoietic cytokines
in human macrophages after infection with immunodeficiency
virus. Blood 1996; 88:3474
42. Moses A, Nelson J, Bagby jr GC. The influence of
human immunodeficiency virus-1 on hematopoiesis. Blood
1998; 91:1479
43. Zauli G, Re MC, Visani G, et al. Inhibitory effect of
HIV-1 envelope glycoprotein gp 120 and gp 160 on the in
vitro growth of enriched (CD 34 + ) hematopoietic progenitor
cells. Arch Virol 1992; 122:271
44. Molina JM, Scadden DJ, Sakaguchi M, et al. Lack of
evidence for infection or effect on growth of hematopoietic
progenitor cells after in vivo or in vitro exposure to human
immunodeficiency virus. Blood 1990; 76:2476
45. Stella CC, Ganser A, Hoelzer D. Defective in vitro
growth of the hemopoietic progenitor cells in the acquired
immunodeficiency syndrome. J Clin Invest 1987; 80:286
46. Donahue RE, Johnson MM, Zon Li, et al. Suppression
of in vitro haematopoiesis following human immunodeficieny
virus infection. Nature, 1987; 326:200
47. Leiderman IZ, Greenberg ML, Adelsberg BR, Siegal
FP. A glycoprotein inhibitor of in vitro granulopoiesis associated
with AIDS. Blood 1987; 70:1267
48. Zauli G, Davis BR, Re MC, et al. Tat protein stimulates
production of transforming growth factor-b1 by marrow
macrophages: a potential mechanism for immunodeficiency
virus-1 induced hematopoietic suppression. Blood
1992; 80:3036
49. Kaplan C, Morinet F, Carlton J. Virus induced autoimmune
thrombocytopenia and neutropenia. Semin.
Hematol 1992; 29:34
50. Groopman JE, Mitsuyasu RT, Deleo MJ, et al. Effect
of recombinant human granulocyte-macrophage colony stimulating
factor on myelopoiesis in the acquired immunodeficiency
syndrome. N Engl J Med, 1987; 317:593
51. Zon Li, Arkin C, Groopman JE. Haematological
manifestations of human immunodeficiency virus (HIV). Br
J Haematol 1987; 66:251
52. Mir N, Costello C, Luckit J, Lindley R. HIV-disease
and bone marrow changes: a study of 60 cases. Eur J
Haematol 1989; 42:339
53. Treacy M, Lai I, Costello C, Clark A. Peripheral